The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2020

Filed:

Dec. 20, 2016
Applicants:

Baxalta Incorporated, Bannockburn, IL (US);

Baxalta Gmbh, Glattpark (Opfikon), CH;

Inventors:

Lucia Gnauer, Eggenburg, AT;

Harald Arno Butterweck, Vienna, AT;

Theresa Bauer, Vienna, AT;

Alfred Weber, Vienna, AT;

Wolfgang Teschner, Vienna, AT;

Hans-Peter Schwarz, Vienna, AT;

Assignees:

Baxalta Incorporated, Bannockburn, IL (US);

Baxalta GmbH, Glattpark (Opfikon), CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 14/47 (2006.01); B01D 15/36 (2006.01); C07K 16/18 (2006.01); B01D 15/16 (2006.01); C07K 16/28 (2006.01); B01D 15/42 (2006.01); C07K 16/06 (2006.01); B01D 61/02 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); B01D 15/16 (2013.01); B01D 15/362 (2013.01); B01D 15/363 (2013.01); B01D 15/426 (2013.01); B01D 61/027 (2013.01); C07K 16/065 (2013.01); C07K 16/2803 (2013.01); A61K 2039/507 (2013.01); B01D 2311/2623 (2013.01); C07K 14/4717 (2013.01); C07K 2317/732 (2013.01);
Abstract

The present invention provides, among other aspects, methods for the manufacture of plasma-derived immunoglobulin G compositions highly enriched for anti-brain disease related protein antibodies (e.g., anti-Aβ, anti-RAGE, and anti-α-synuclein antibodies). Advantageously, the methods provided do not affect the manufacturing processes or capabilities for producing plasma-derived IgG therapeutics. Plasma-derived IgG compositions that are highly enriched for anti-brain disease related protein antibodies (e.g., anti-Aβ, anti-RAGE, and anti-α-synuclein antibodies), as also provided here. Methods for the treatment of brain diseases and disorders by administration of plasma-derived IgG compositions highly enriched for anti-brain disease related protein antibodies (e.g., anti-Aβ, anti-RAGE, and anti-α-synuclein antibodies), are also provided.


Find Patent Forward Citations

Loading…